PacBio (PACB) announced the appointment of Chris Smith to its Board of Directors, effective today. Smith is currently the Chief Executive Officer of NeoGenomics (NEO).
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PACB:
- PacBio announces role in study to be published in Nature Genetics
- Largest borrow rate increases among liquid names
- PacBio announces GIFS at USask as first Revio PacBio CSP in Canada
- PacBio, Radboud UMC announces study results using HiFi long read sequencing
- PacBio reports Q4 preliminary revenue $39.2M, consensus $40.63M